Pluri Inc. Proceeds from Sale of Available-for-sale Securities
Pluri Inc. (PLUR) reported Proceeds from Sale of Available-for-sale Securities of $21.88 million for the 12-month period ending 2018-06-30, per its 10-K filed 2020-09-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2020-09-10
- Pluri Inc. proceeds from sale of available-for-sale securities for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Pluri Inc. proceeds from sale of available-for-sale securities for the quarter ending 2018-03-31 was $12.87M, a 1490.98% increase year-over-year.
- Pluri Inc. proceeds from sale of available-for-sale securities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Pluri Inc. proceeds from sale of available-for-sale securities for the quarter ending 2017-09-30 was $9.01M, a 229.80% increase year-over-year.
- Pluri Inc. proceeds from sale of available-for-sale securities for fiscal 2018 was $21.88M, a 295.89% increase from fiscal 2017.
- Pluri Inc. proceeds from sale of available-for-sale securities for fiscal 2017 was $5.53M, a 21.03% decline from fiscal 2016.
- Pluri Inc. proceeds from sale of available-for-sale securities for fiscal 2016 was $7.00M, a 34.19% decline from fiscal 2015.
- Pluri Inc. proceeds from sale of available-for-sale securities for fiscal 2015 was $10.63M, a 73.97% increase from fiscal 2014.
| Period end | Proceeds from Sale of Available-for-sale Securities 1 month | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|---|
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $12.87M derived: sum of 2 quarters · filed 2020-09-10 | $12.87M derived: sum of 3 quarters · filed 2020-09-10 | $21.88M 10-K · filed 2020-09-10 | |
| 2018-03-31 | $12.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $12.87M derived: sum of 2 quarters · filed 2019-05-06 | $21.88M 10-Q · filed 2019-05-06 | $22.79M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $9.01M 10-Q · filed 2019-02-06 | $9.91M derived: sum of 3 quarters · filed 2019-09-12 | $10.72M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-09-30 | $9.01M 10-Q · filed 2018-11-07 | $9.91M derived: sum of 2 quarters · filed 2019-09-12 | $10.72M derived: sum of 3 quarters · filed 2019-09-12 | $11.80M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-06-30 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $1.71M derived: sum of 2 quarters · filed 2019-09-12 | $2.79M derived: sum of 3 quarters · filed 2019-09-12 | $5.53M 10-K · filed 2019-09-12 | |
| 2017-03-31 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $1.89M derived: sum of 2 quarters · filed 2018-05-09 | $4.62M 10-Q · filed 2018-05-09 | $8.76M derived: sum of 4 quarters · filed 2018-09-12 | |
| 2016-12-31 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $3.81M 10-Q · filed 2018-02-06 | $7.95M derived: sum of 3 quarters · filed 2018-09-12 | $9.76M derived: sum of 4 quarters · filed 2018-09-12 | |
| 2016-09-30 | $2.73M 10-Q · filed 2017-11-07 | $6.87M derived: sum of 2 quarters · filed 2018-09-12 | $8.68M derived: sum of 3 quarters · filed 2018-09-12 | $9.21M derived: sum of 4 quarters · filed 2018-09-12 | |
| 2016-06-30 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $5.95M derived: sum of 2 quarters · filed 2018-09-12 | $6.48M derived: sum of 3 quarters · filed 2018-09-12 | $7.00M 10-K · filed 2018-09-12 | |
| 2016-03-31 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $2.35M derived: sum of 2 quarters · filed 2017-05-08 | $2.86M 10-Q · filed 2017-05-08 | $3.62M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-12-31 | $537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $1.05M 10-Q · filed 2017-02-08 | $1.81M derived: sum of 3 quarters · filed 2017-09-07 | $9.28M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-09-30 | $517.00K 10-Q · filed 2016-11-07 | $1.27M derived: sum of 2 quarters · filed 2017-09-07 | $8.74M derived: sum of 3 quarters · filed 2017-09-07 | $11.12M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-06-30 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $8.23M derived: sum of 2 quarters · filed 2017-09-07 | $10.60M derived: sum of 3 quarters · filed 2017-09-07 | $10.63M 10-K · filed 2017-09-07 | |
| 2015-03-31 | $5.72M 10-K · filed 2015-09-09 | $7.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $9.84M derived: sum of 2 quarters · filed 2016-05-09 | $9.88M 10-Q · filed 2016-05-09 | $12.12M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-12-31 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $2.41M 10-Q · filed 2016-02-08 | $4.65M derived: sum of 3 quarters · filed 2016-09-07 | $5.56M derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-09-30 | $37.00K 10-Q · filed 2015-11-05 | $2.27M derived: sum of 2 quarters · filed 2016-09-07 | $3.19M derived: sum of 3 quarters · filed 2016-09-07 | $4.28M derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-06-30 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $3.15M derived: sum of 2 quarters · filed 2016-09-07 | $4.24M derived: sum of 3 quarters · filed 2016-09-07 | $6.11M 10-K · filed 2016-09-07 | |
| 2014-03-31 | $912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $2.00M derived: sum of 2 quarters · filed 2015-05-06 | $3.88M 10-Q · filed 2015-05-06 | $5.04M derived: sum of 4 quarters · filed 2015-09-09 | |
| 2013-12-31 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $2.96M 10-Q · filed 2015-02-05 | $4.13M derived: sum of 3 quarters · filed 2015-09-09 | $4.35M derived: sum of 4 quarters · filed 2015-09-09 | |
| 2013-09-30 | $1.87M 10-Q · filed 2014-11-06 | $3.04M derived: sum of 2 quarters · filed 2015-09-09 | $3.26M derived: sum of 3 quarters · filed 2015-09-09 | $3.40M derived: sum of 4 quarters · filed 2015-09-09 | |
| 2013-06-30 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $1.39M derived: sum of 2 quarters · filed 2015-09-09 | $1.53M derived: sum of 3 quarters · filed 2015-09-09 | $1.85M 10-K · filed 2015-09-09 | |
| 2013-03-31 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-08 | $366.00K derived: sum of 2 quarters · filed 2014-05-08 | $679.00K 10-Q · filed 2014-05-08 | ||
| 2012-12-31 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $459.00K 10-Q · filed 2014-02-05 | |||
| 2012-09-30 | $313.00K 10-Q · filed 2013-11-05 | ||||
| 2012-06-30 | $884.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |